| Title |
Now is the Critical Time for Engineered Neuroplasticity
|
|---|---|
| Published in |
Neurotherapeutics, June 2018
|
| DOI | 10.1007/s13311-018-0637-0 |
| Pubmed ID | |
| Authors |
Chet T. Moritz |
| Abstract |
Recent advances in neuroscience and devices are ushering in a new generation of medical treatments. Engineered biodevices are demonstrating the potential to create long-term changes in neural circuits, termed neuroplasticity. Thus, the approach of engineering neuroplasticity is rapidly expanding, building on recent demonstrations of improved quality of life for people with movement disorders, epilepsy, and spinal cord injury. In addition, discovering the fundamental mechanisms of engineered neuroplasticity by leveraging anatomically well-documented systems like the spinal cord is likely to provide powerful insights into solutions for other neurotraumas, such as stroke and traumatic brain injury, as well as neurodegenerative disorders, such as Alzheimer's, Parkinson disease, and multiple sclerosis. Now is the time for advancing both the experimental neuroscience, device development, and pioneering human trials to reap the benefits of engineered neuroplasticity as a therapeutic approach for improving quality of life after spinal cord injury. |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 17 | 77% |
| Unknown | 5 | 23% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 50% |
| Scientists | 5 | 23% |
| Practitioners (doctors, other healthcare professionals) | 4 | 18% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
| Unknown | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 135 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 15% |
| Student > Ph. D. Student | 17 | 13% |
| Student > Master | 14 | 10% |
| Student > Bachelor | 14 | 10% |
| Other | 10 | 7% |
| Other | 28 | 21% |
| Unknown | 32 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 22 | 16% |
| Engineering | 21 | 16% |
| Medicine and Dentistry | 18 | 13% |
| Nursing and Health Professions | 10 | 7% |
| Psychology | 7 | 5% |
| Other | 19 | 14% |
| Unknown | 38 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2021.
All research outputs
#1,402,412
of 25,382,440 outputs
Outputs from Neurotherapeutics
#102
of 1,308 outputs
Outputs of similar age
#29,700
of 341,432 outputs
Outputs of similar age from Neurotherapeutics
#1
of 22 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,432 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.